Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) today announced its partnership with Lundbeck Export A/S (“Lundbeck”) and their portfolio of brain diseases drugs in Taiwan. Under the partnership, Bora will be exclusively responsible for sales and marketing of Lundbeck’s products through Bora’s specialized hospital, clinic, and drug store channels in Taiwan effective from January 1st, 2024.
Brain diseases, including neurological and psychiatric disorders, are complex conditions often invisible to others that nonetheless take a tremendous toll on individuals, families and societies. Treating brain diseases is estimated to cost around 10% of the world’s GDP and, according to the World Health Organization, two of the most common mental health conditions, depression and anxiety, cost the global economy at least US$1 trillion each year.
Lundbeck, headquartered in Denmark, is a global pharmaceutical company specialized in developing innovative treatments for brain diseases. With products registered in more than 100 countries around the world, Lundbeck helps more than 8 million people living with brain diseases, such as Parkinson’s diseases, Alzheimer’s diseases, epilepsy, depression, anxiety, and psychosis. By partnering with Lundbeck, Bora has further enhanced its product portfolio in the CNS category to ensure the patients in Taiwan with an access to more novel medical solutions for better lives.
Bobby Sheng, CEO and Chairman of Bora, said “we are extremely excited about this partnership with Lundbeck and to continue to provide patients in Taiwan with the best-in-class medical solutions. Brain diseases are and increasingly serious issue around the world. The fact that people suffering from brain diseases live an average of 10 to 20 years less than healthy individuals is something that everyone should be concerned about. As being a trusted global partner for many multinational pharmaceutical and biotech companies, we are committed to working closely with Lundbeck to enhance access to brain health for the people of Taiwan.”
